phase-iii

Emergency use authorization request filed with FDA for paediatric use of Bharat Biotech's Covaxin-

DCGI allows Bharat Biotech to conduct phase-III trials for COVID’s intranasal booster dose-

admin

By PTI NEW DELHI/ HYDERABAD: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for ...